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Background
CD4 T-lymphocytes play a prominent role in Type 1 DM.
The NOD mouse is a model for this autoimmune disease.
The earliest histological signs of autoimmunity in female
NOD mice occur at approximately 5 weeks of age. We
hypothesized that this process may be preceded by molec-
ular events in the CD4 T-lymphocytes. To test this hypoth-
esis, we analyzed the transcriptomes of CD4 T-
lymphocytes of young "prepathologic" NOD mice.
Methods
Using a magnetic separation system (Miltenyi Biotec), we
isolated CD4 T-lymphocytes from spleen leukocytes of
female NOD mice, and two control strains, NOR and
C57Bl/6, at 2, 3, and 4 weeks of age (n = 5 for each strain,
except for NOD 2 wk where n = 4). CD4 T-lymphocyte
transcriptomes were characterized on Affymetrix Mouse
430_2 expression arrays probing ~39,000 mouse genes/
ESTs. Gene lists produced from statistical analyses were
mined using Ingenuity Pathway Analysis http://
www.ingenuity.com.
Results
Analysis by 1-way ANOVA (p < 0.005, Benjamin-Hoch-
berg Multiple Test Correction (MTC) defined 311, 624,
and 581 probesets (genes) with highly significant expres-
sion differences between strains at 2, 3 and 4 weeks,
respectively. Hierarchical clustering of these probeset lists
identified 58, 115, and 65 probesets, respectively for 2, 3,
and 4 week old mice, as being differentially expressed in
NOD mice relative to both control strains (17, 32, and 9
were upregulated in NOD mice while 41, 83, and 56 were
downregulated). Pathway analysis of the 3 gene lists (58,
115 and 64 probesets) revealed that 7 (HNF4A, IFNG, IL4,
TP53, BCL2L1, IL15, and prostaglandin E2) of the top 15
central genes in each network were common to all age
groups. IL6 was central in networks of 2 and 4 week old
mice but not of 3 week old mice. Uniquely central to indi-
vidual networks were: MYC, JUN and HRAS at 2 weeks;
TNF, NFKB, p38MAPK, and TGFB1 at 3 weeks; and Inter-
feron alpha, IL12 and STAT4 at 4 weeks.
Conclusion
We conclude that young, prediabetic NOD mice have
basic (i.e. common, most likely genetic) molecular defects
in CD4 T-cells associated with apoptosis/cellular prolifer-
ation, Th1-Th2 differentiation and cytokine signaling.
Furthermore, abnormalities in apoptosis/cellular prolifer-
ation predominate at 2 weeks of age while those in cellu-
lar activation/acute phase response signaling and
inflammation predominate in 3 week old mice. Finally,
abnormalities in the innate immune response and its link
to the adaptive immune response are evident at 4 weeks of
age.
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